Immunohistochemical localization of afatinib in male rat intestines and skin after its oral administration

This publication has 20 references indexed in Scilit:

• Optimizing outcomes in EGFR Mutation-Positive Nsclc: Which Tyrosine Kinase Inhibitor and When?
  Future Oncology, 2018
• Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter
  Oncogene, 2016
• Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation
  Journal of Dermatological Science, 2013
• Dacomitinib, a new therapy for the treatment of non-small cell lung cancer
  Expert Opinion on Pharmacotherapy, 2013
• Immunocytochemistry for Vancomycin Using a Monoclonal Antibody That Reveals Accumulation of the Drug in Rat Kidney and Liver
  Antimicrobial Agents and Chemotherapy, 2012
• Managing Treatment-Related Adverse Events Associated with egfr Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer
  Current Oncology, 2011
• Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers
  Journal of Oncology, 2009
• Drug Insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy
  Nature Clinical Practice Oncology, 2008
• Detection of 5-bromodeoxyuridine (BrdUrd) incorporation by monoclonal antibodies: role of the DNA denaturation step.
  Journal of Histochemistry & Cytochemistry, 1985
• Distribution and number of epidermal growth factor receptors in skin is related to epithelial cell growth
  Developmental Biology, 1983